MUDr. Gregar, s.r.o.

Olomouc, Olomouc Region 779 00

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed